CSS
ARIA

Cubist Systematic Strategies’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Cubist Systematic Strategies’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,100
Closed -$51K – 2039
2016
Q4 		$51K Sell
4,100
-6,963
-63% -$83.9K ﹤0.01% 1580
2016
Q3 		$151K Buy
11,063
+2,529
+30% +$25.4K 0.01% 1368
2016
Q2 		$63K Sell
8,534
-86,181
-91% -$647K ﹤0.01% 1568
2016
Q1 		$605K Sell
94,715
-55,961
-37% -$314K 0.03% 684
2015
Q4 		$942K Sell
150,676
-6,930
-4% -$45.5K 0.06% 495
2015
Q3 		$920K Sell
157,606
-17,594
-10% -$136K 0.05% 631
2015
Q2 		$1.45M Buy
175,200
+136,450
+352% +$1.21M 0.07% 388
2015
Q1 		$319K Buy
38,750
+22,493
+138% +$166K 0.02% 1220
2014
Q4 		$112K Buy
+16,257
New +$102K 0.01% 1675

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Cubist Systematic Strategies's ARIA Position: Q1 2017 in Review

Cubist Systematic Strategies sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 4,100 shares — an estimated $51K sold.

Cubist Systematic Strategies first reported a position in ARIA in Q4 2014 and held it in 9 quarters. The position peaked at $1.45M in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Cubist Systematic Strategies reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 4,100 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $51K.
  • Cubist Systematic Strategies first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 9 quarters.
  • Cubist Systematic Strategies's Ariad Pharmaceuticals Inc position peaked at $1.45M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Cubist Systematic Strategies's 13F filing for Q1 2017, filed 15 May 2017.